FDA.reportPublic FDA data

atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule

RxCUI
664741
RxNorm name
atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule
Display name
atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule
Full name
atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Atazanavir SulfateATAZANAVIRAurobindo Pharma Limited7fbea274-d6b5-4faa-bbf0-05fefab421142025-08-06Warnings, Adverse reactionsExact identifier
rxcui: 664741
AtazanavirATAZANAVIRLaurus Labs Limitedc98e40ec-8a2c-4f19-b1c3-c82f708c24902025-06-02Warnings, Adverse reactionsExact identifier
rxcui: 664741
AtazanavirATAZANAVIRCamber Pharmaceuticals, Inc.8a0c609f-e296-4925-a35c-e93a044676552025-03-17Warnings, Adverse reactionsExact identifier
rxcui: 664741
Atazanavir SulfateATAZANAVIR SULFATETeva Pharmaceuticals USA, Inc.654b7e08-33d8-47e7-b37f-3681e79c7b8b2024-12-30Warnings, Adverse reactionsExact identifier
rxcui: 664741
REYATAZATAZANAVIRE.R. Squibb & Sons, L.L.C.165cff62-b284-4a27-a65d-9ec8a5bfcdd82024-12-05Warnings, Adverse reactionsExact identifier
rxcui: 664741

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
165cff62-b284-4a27-a65d-9ec8a5bfcdd8atazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]337These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ ® (atazanavir) capsules, for oral use REYATAZ ® (atazanavir) oral powder Initial U.S. Approval: 200320241205
654b7e08-33d8-47e7-b37f-3681e79c7b8batazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]314These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320241230
7fbea274-d6b5-4faa-bbf0-05fefab42114atazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]38These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320250806
c98e40ec-8a2c-4f19-b1c3-c82f708c2490atazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]34These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320250602
4f424439-c809-22fc-e054-00144ff8d46catazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]3320220120
8a0c609f-e296-4925-a35c-e93a04467655atazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]32These highlights do not include all the information needed to use ATAZANAVIR CAPSULES safely and effectively. See full prescribing information for ATAZANAVIR CAPSULES. ATAZANAVIR capsules, for oral use Initial U.S. Approval: 200320250317
025876b6-f031-43ea-967a-b1d95b4685a6atazanavir sulfate 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [SCD] · atazanavir 300 MG (as atazanavir sulfate 341.69 MG) Oral Capsule [SY]32These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ ® (atazanavir sulfate) Capsules Initial U.S. Approval: 200320120217